Totally thoracoscopic repair of atrial septal defect: A single-center clinical study
- VernacularTitle:全胸腔镜下房间隔缺损修补手术单中心临床研究
- Author:
LAN Huai
1
;
CHENG Yunge
2
;
JIA Baocheng
2
;
CHAI Yuliang
2
Author Information
1. Department of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, 110016, P.R.China
2. Department of Thoracoscopic Cardiac Surgery, Shanghai Yodak Cardiothoracic Hospital, Shanghai, 200235, P.R.China
- Publication Type:Journal Article
- Keywords:
Thoracoscopy;
minimally invasive cardiac surgery;
atrial septal defect
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(03):264-267
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize the experience of totally thoracoscopic cardiac surgery (TTCS) for atrial septal defect. Methods Clinical data of 442 patients undergoing TTCS for atrial septal defect from May 2008 to December 2018 in Shanghai Yodak Cardiothoracic Hospital was analyzed retrospectively. There were 149 male and 293 female patients, aged 3-74 (29.1±14.3) years. Surgical procedures were performed through 3 ports at the right chest wall. Results All the operations were completed successfully. Mean operative time was 1.5-4.6 (2.2±0.3) h. The mean extracorporeal circulation and aortic cross-clamp time was 28-118 (55.9±13.3) min and 8-78 (21.5±10.2) min, respectively. Mechanical ventilation and intensive care unit stay time was 3.5-122.0 (8.1±7.4) h and 13-141 (20.7±10.2) h, respectively. Postoperation drainage volume was 70-1 280 (251.8±131.5) mL. The hospital stay was 4-16 (7.1±1.4) d. Intraoperative and postoperative complications occurred in 15 patients (3.3%). The mean follow-up time was 1-128 (67.6±33.3) months, and during the period, there were 25 patients of atrial fibrillation, 25 patients of mild-moderate tricuspid valve incompetence, 1 patient of moderate tricuspid valve incompetence. There was no reoperation or residual shunt during the period of follow-up. And the heart function was improved. Conclusion TTCS is a feasible, safe and minimal invasive approach for patients with atrial septal defect and has good short to medium-term outcomes.
